{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:31Z","timestamp":1792788991361,"version":"4.5.0"},"reference-count":50,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/21645515.2021.1996808","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T18:31:31Z","timestamp":1639161091000},"page":"5603-5613","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-4428","authenticated-orcid":false,"given":"Mar\u00eda Gabriela","family":"Gra\u00f1a","sequence":"first","affiliation":[{"name":"GSK","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Cavada","sequence":"additional","affiliation":[{"name":"Universidad de Chile","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7818-8221","authenticated-orcid":false,"given":"Marjorie","family":"Vasquez","sequence":"additional","affiliation":[{"name":"GSK","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-5003","authenticated-orcid":false,"given":"Jing","family":"Shen","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7086-8436","authenticated-orcid":false,"given":"Johan","family":"Maervoet","sequence":"additional","affiliation":[{"name":"Parexel","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-7685","authenticated-orcid":false,"given":"Johan","family":"Klint","sequence":"additional","affiliation":[{"name":"Parexel International","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-4973","authenticated-orcid":false,"given":"Jorge A.","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"GSK","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1258308"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.05.006"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1532248"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268805005339"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(10)70251-6"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70180-1"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000043"},{"key":"e_1_3_5_9_1","unstructured":"Ministerio de Salud. Bolet\u00edn Epidemiol\u00f3gico Trimestral - Enfermedad Meningoc\u00f3cica SE 1 \u2013 52. 2019 [accessed 2021 May 6]. http:\/\/epi.minsal.cl\/wp-content\/uploads\/2020\/01\/BET_MENINGITIS_A%C3%91O_-2019.pdf."},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1458175"},{"key":"e_1_3_5_12_1","unstructured":"World Health Organization (WHO). WHO position paper on meningococcal vaccines. 2011 [accessed 2021 Apr 19]. https:\/\/www.who.int\/immunization\/position_papers\/PP_meningococcal_November_2011_presentation.pdf?ua=1."},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0196-z"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.023"},{"key":"e_1_3_5_15_1","unstructured":"GSK. Bexsero - Vacuna Meningoc\u00f3cica Multicomponente del Grupo B. [accessed 2021 May 6]. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/es_CL\/PDFs\/Homepage\/products\/bexsero\/CL_IP_Bexsero.pdf."},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1244"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00370-x"},{"key":"e_1_3_5_18_1","volume-title":"Presented at: European Society for Paediatric Infectious Diseases, 37th Annual Meeting","author":"Pizza M","year":"2019","unstructured":"Pizza M, Biolchi A, De Angelis G, Moschioni M, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, Claus H, et al. Abstract ESPID19-0255: a multicomponent meningococcal serogroup B vaccine developed for serogroup B meningococci elicits cross-reactive immunity against serogroups C, W and Y. Presented at: European Society for Paediatric Infectious Diseases, 37th Annual Meeting, Ljubljana, Slovenia; 2019."},{"key":"e_1_3_5_19_1","unstructured":"GSK. US prescribing information: Menveo. 2010 [accessed 2021 Apr 19]. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Menveo\/pdf\/MENVEO.PDF."},{"key":"e_1_3_5_20_1","unstructured":"GSK. Menveo - Vacuna conjugada contra meningococo de los serogrupos A C W-135 e Y. 2018 [accessed 2021 May 6]. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/es_CL\/PDFs\/Homepage\/products\/Menveo\/CL_IP_Menveo.pdf."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)60842-4"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.4067\/s0716-10182013000400002"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.4067\/s0034-98872013000800001"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.050"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2015.12.011"},{"key":"e_1_3_5_26_1","unstructured":"Ministerio de Salud. Recomendaciones para la vacunaci\u00f3n de pacientes con necesidades especiales por patolog\u00edas o situaciones de riesgo. 2018 [accessed 2021 Jun 9]. https:\/\/vacunas.minsal.cl\/wp-content\/uploads\/2020\/02\/Recomendaciones-para-la-vacunaci%C3%B3n-de-pacientes-con-necesidades-especiales.pdf."},{"key":"e_1_3_5_27_1","unstructured":"Ministerio de Salud. Ord-B27-N\u00b0-4293-Informa incorporacion de la vacuna antimeningococica del grupo B. 2019 [accessed 2021 Jun 9]. https:\/\/vacunas.minsal.cl\/wp-content\/uploads\/2020\/07\/Ord-B27-N%C2%B0-4293-Informa-incorporacion-de-la-vacuna-antimeningococica-del-grupo-B-del-Lab.-Glaxosmithkline-23-sept-2019.pdf."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.007"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.09.004"},{"key":"e_1_3_5_30_1","unstructured":"El Instituto Nacional de Estad\u00edsticas. Censo 2017. 2017 [accessed 2020 Jul 7]. https:\/\/www.censo2017.cl\/."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.4067\/s0034-98872019000600776"},{"key":"e_1_3_5_32_1","unstructured":"Health statistics Department Chile. Nacimientos. 2020 [accessed 2021 Jun 9]. https:\/\/deis.minsal.cl\/#estadisticas."},{"key":"e_1_3_5_33_1","unstructured":"Health Statistics Department Chile. Defunciones y Mortalidad General. 2020 [accessed 2021 Jun 9]. https:\/\/deis.minsal.cl\/#estadisticas."},{"key":"e_1_3_5_34_1","unstructured":"Gobierno de Chile. Solicitud de Informaci\u00f3n Ley de Transparencia. 2008 [accessed 2021 Jun 9]. http:\/\/transparencia.redsalud.gov.cl\/transparencia\/public\/isp\/solicitud_informacion.html."},{"key":"e_1_3_5_35_1","unstructured":"Health statistics Department Chile. Hospital discharge database 2012\u20132018 - Egresos hospitalarios. 2020 [accessed 2021 Jun 9]. https:\/\/deis.minsal.cl\/#estadisticas."},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182706b89"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.015"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix091"},{"key":"e_1_3_5_39_1","unstructured":"Departamento de Estad\u00edsticas e Informaci\u00f3n de Salud. Cobertura de vacunaci\u00f3n program\u00e1tica Infantil 2019\u20132020. 2019 [accessed 2020 Aug 19]. https:\/\/deis.minsal.cl\/."},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193572"},{"key":"e_1_3_5_41_1","volume-title":"Presented at: 15th European Meningococcal and Haemophilus Disease Society (EMGM) Congress","author":"Rodrigues F","year":"2019","unstructured":"Rodrigues F. Portuguese meningococcus group B vaccine effectiveness study (PT-BEST) - preliminary results. Presented at: 15th European Meningococcal and Haemophilus Disease Society (EMGM) Congress; 2019; Lisbon, Portugal."},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2193"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.12.005"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000897"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1058457"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000438"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.09.034"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00291-9"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166475"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.26633\/rpsp.2017.118"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.055"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1996808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2021.1996808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1996808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:23:50Z","timestamp":1786991030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1996808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/21645515.2021.1996808"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1996808","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}